Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z




DISSS Home | Contact Us
 Health and Human Services Logo



Animated FirstGov Logo - Click to enter FirstGov


Rocky Mountain Spotted Fever (Rickettsia rickettsii) (RMSF)

Contents
Home - National Notifiable Diseases Surveillance System
Overview
Introduction
List of Nationally Notifiable Diseases
Alphabetical List of Case Definitions
Definition of Terms
Related Links
References
  Site Search


1996 Case Definition

Clinical description

A tickborne febrile illness most commonly characterized by acute onset and usually accompanied by myalgia, headache, and petechial rash (on the palms and soles in two thirds of the cases)

Laboratory criteria for diagnosis

  • Fourfold or greater rise in antibody titer to Rickettsia rickettsii antigen by immunofluorescence antibody (IFA), complement fixation (CF), latex agglutination (LA), microagglutination (MA), or indirect hemagglutination antibody (IHA) test in acute- and convalescent-phase specimens ideally taken greater than or equal to 3 weeks apart, or
  • Positive polymerase chain reaction assay to R. rickettsii, or
  • Demonstration of positive immunofluorescence of skin lesion (biopsy) or organ tissue (autopsy), or
  • Isolation of R. rickettsii from clinical specimen

Case classification

Probable: a clinically compatible case with a single IFA serologic titer of greater than or equal to 64 or a single CF titer of greater than or equal to 16 or other supportive serology (fourfold rise in titer or a single titer greater than or equal to 320 by Proteus OX-19 or OX-2, or a single titer greater than or equal to 128 by an LA, IHA, or MA test)

Confirmed: a clinically compatible case that is laboratory confirmed

See also:

Printable Version

 


 



Privacy Policy | Accessibility

DISSS Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated January 9, 2008

United States Department of Health and Human Services
Centers for Disease Control and Prevention

"Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC).